Meet Our Team
We make in India with Scientific Talent in India
We work to accelerate translation of innovative discoveries into therapeutics
We are a leading-edge translational biotechnology company focused on developing personalized in-vitro and in-vivo modalities using stem cell / patient-derived tumors (PDX platforms) for various diseases including cancer. We enable personalized treatments for cancers and other unmet medical conditions, and screen drug molecules.
We follow the 3 R's Principle – Replacement, Reduction and Refinement in case of experimental animal usage as an alternative. We like to replace animal experiments with invitro methods. We diligently try to find alternatives to use of animals in research. But when the usage of animals is needed we reduce the numbers and refine our practices.
We aim to help the medical oncologists and Pharma R&D take an informed decision in real-time, to treat their patients, or discover new therapeutics by creating stem cell or in vitro patient tumor-derived Organoids/Spheroids platform.
Dr. Suresh Poosala is the Founder and President of OncoSeek Bio Pvt Ltd. He is an Advisor to The Jackson Laboratory; Council Member, AAALAC International, Strategic Advisor, Science in India, The Jackson Laboratory, USA Committee member-Antibiotic Residues, FSSAI, GOI, India, and Consultant for in vivo Regulatory and Facilities Accreditations, Pacific Rim Executive Member, Federation of Asian Biologists Association (FABA). He is a leader, scientist and motivator with three decades of international experience in fostering science, innovation and collaborative culture, by building and nurturing high-performing teams. His career spans scientific excellence in discovery and research, which resulted in high impact publications in high visibility international journals including Nature and he created exceptional quality in vivo facilities and created trained teams for R&D. He has succeeded as a leader in enabling great collaborations between CROs and Discovery programs, academia and industry, and between many strategic partners. He returned to India after 25 years at NIH, Washington, Bristol-Myers Squibb, San Francisco, University of Maryland, Baltimore, and St. Jude’s Research, Memphis. He launched a startup after his return to India and is participating in several active advisory roles and partnerships, his way of giving back to Science in India.
Dr. Bharadwaja Vadloori is a Senior Scientist at OncoseekBio Pvt Ltd. He is a Masters in Biochemistry from Banaras Hindu University and a Ph.D. in Infection Biology from the University of Hyderabad. He is basically a Biochemist, with Immunology, Microbiology (Infectious diseases) background and Analytical Skills for Identifying, Scrutinizing, Improving, and Streamlining Complex Work Processes. His research was on drug discovery for Visceral Leishmaniasis. As a Senior Scientist at OncoseekBio, he excels at building and nurturing high-performing teams, building relationships with clients and colleagues towards performing interdisciplinary research. Currently, he performs various roles and oversees scientific projects.
Saimatha is a Research Associate at Oncoseek Bio Pvt. Ltd. She has expertise in areas of research that utilize in vivo and in vitro skills. She has 6 years of research experience from Indian Institute of Science (IISc), Bangalore. Her areas of expertise include Molecular biology, Immunology, Cell biology, Protein biochemistry, Microbiology and Biophysics. She has experience of testing various natural and synthetic compounds on cancerous cell lines and other cells. Prior to IISc, she worked as a Lecturer in SKBR college, Amalapuram, affiliated to Andhra University, where she taught Biotechnology to Bachelors and Masters students. She completed her Masters in Biosciences from Sri Sathya Institute of Higher Learning, Prashanthi Nilayam.
Ms. Shanmugapriya Shanmugasundaram is a Junior Scientist at OncoseekBio Pvt Ltd. She is a Master's Biotechnology from SRM arts and science college, Chennai. She is experienced in Mammalian Cell Culture, Various Cytotoxicity, Genotoxicity assays, and Molecular Biology Techniques and She is a resourceful team player and has the ability to prioritize and schedule to work both independently and collaboratively to meet targets. As a Junior Scientist, she takes care of the cell culture lab at OncoseekBio.
Dr. Uday Saxena is Co-Founder and Chief Ideator of Reagene Biosciences. He was Mentor-in-Residence and Professor of Translational Research at Dr. Reddy’s Institue of Life Sciences. He has held Executive and Leadership positions at Parke-Davis, AtheroGenics, Dr.Reddy’s Laboratories and Kareus Therapeutics. He obtained his Ph.D. in Biochemistry from Memorial University, Canada and Post-doc from Columbia University. He likes to use “disruptive science” to discover and understand new therapies.
Dr. Jugnu Jain is Co-Founder and CEO of Sapien Biosciences and Saarum Sciences. She has more than 25 years of molecular and cell biology experience in cancer, immunology, neurology, diabetes and played leadership roles at Vertex Pharmaceuticals, USA and UK. She obtained her Ph.D. in genetics from Cambridge and Post-doc in immunology from Harvard. Currently, she is creating a bio-bank of primary cells and Indian cell lines collection to spur understanding of Indian diseases and genetic variants.
Dr. Sreedhara Voleti is the CEO of ASPIRE – BioNEST, University of Hyderabad and Founder, Managing Director of INDRAS Pvt. Ltd. He is a passionate entrepreneur, consultant, start-up entertainer, leader, and mentor with over 20 years of pharma R & D experience. He was Co-Founder and CSO at Theraxel Discoveries Pvt. Ltd and Head of CADD at Ranbaxy and ILS. He obtained his Ph.D. from IISc Bangalore and Post-Docs from University of Massachusetts and Washington State University, USA.